XML 24 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure
12 Months Ended
Dec. 31, 2024
USD ($)
uSD
Dec. 31, 2023
USD ($)
uSD
Dec. 31, 2022
USD ($)
uSD
Dec. 31, 2021
USD ($)
uSD
Dec. 31, 2020
USD ($)
uSD
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
PAY VERSUS PERFORMANCE
As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, we are providing the information below to illustrate the relationship between the SEC-defined compensation actually paid (“CAP”) and various measures used to gauge the Company’s financial performance in conformance with Item 402(v) of Regulation S-K. CAP is calculated in accordance with Item 402(v) of Regulation S-K and differs from compensation shown in the Summary Compensation Table on page 38 for the CEO and other NEOs. See below for a reconciliation of the total compensation shown in the Summary Compensation Table to CAP. The Compensation Committee does not utilize CAP as the basis for making compensation decisions. For further information concerning our compensation philosophy and how we align executive compensation with our performance, see the Compensation Discussion and Analysis section beginning on page 24.
The following table sets forth information concerning the compensation of our NEOs for each of the fiscal years ended December 31, 2020, 2021, 2022, 2023 and 2024 and our financial performance for each such fiscal year:
Year
Summary Compensation Table Total for PEO ($)(1)
Compensation Actually Paid to PEO ($)(2)
Average Summary Compensation Table Total for Non-PEO NEOs ($)(1)
Average Compensation Actually Paid to Non-PEO NEOs ($)(2)
Value of Initial Fixed $100 Investment Based on(3)
Net Income ($)
Adjusted EBITDA ($)(4)
Total Shareholder Return ($)
Peer Group Total Shareholder Return ($)
20242,241,872 2,647,343 1,087,215 1,227,807 204 92 14,965,000 29,173,000 
20232,371,861 4,206,220 1,139,797 1,765,153 182 84 15,666,000 30,342,000 
20222,241,962 1,987,036 1,091,234 1,016,795 87 115 21,856,000 14,965,000 
20212,118,609 1,715,235 909,767 778,886 84 135 (22,180,000)(4,892,000)
20202,089,573 1,823,662 863,198 796,888 96 115 (44,225,000)6,346,000 
       
Company Selected Measure Name Adjusted EBITDA        
Named Executive Officers, Footnote Total compensation earned during the fiscal year as presented within the Summary Compensation Table on Page 38, during each year in the table above. Mr. Vince Kelly is represented as the principal executive officer ("PEO") for the years shown. For performance years 2024, 2023 and 2022, Mr. Calvin Rice, Mr. Michael Wallace and Ms. Sharon Woods Keisling are represented as the non-PEO NEOs. For the performance years 2021 and 2020, Mr. Michael Wallace and Ms. Sharon Woods Keisling are represented as the non-PEO NEOs.        
Peer Group Issuers, Footnote Total Shareholder Return is cumulative for the measurement periods beginning on December 31, 2019 and ending on the last fiscal day in 2024, 2023, 2022, 2021 and 2020, respectively, calculated in accordance with Item 201(e) of Regulation S-K. “Peer Group” represents the S&P Composite 1500 Healthcare Technology Index for each year disclosed in the table.        
PEO Total Compensation Amount $ 2,241,872 $ 2,371,861 $ 2,241,962 $ 2,118,609 $ 2,089,573
PEO Actually Paid Compensation Amount $ 2,647,343 4,206,220 1,987,036 1,715,235 1,823,662
Adjustment To PEO Compensation, Footnote
Appendix A: The following adjustments were made to the total compensation paid to the PEO and the average total compensation paid to the Non-PEO NEOs to arrive at CAP, in accordance with SEC rules.
       
Non-PEO NEO Average Total Compensation Amount $ 1,087,215 1,139,797 1,091,234 909,767 863,198
Non-PEO NEO Average Compensation Actually Paid Amount $ 1,227,807 1,765,153 1,016,795 778,886 796,888
Adjustment to Non-PEO NEO Compensation Footnote CAP to our NEOs represents the "Total" compensation reported in the Summary Compensation Table for the applicable fiscal year, as adjusted for the adjustments in Appendix A.        
Compensation Actually Paid vs. Total Shareholder Return
CAP versus Company TSR and Peer Group TSR
TSR amounts reported in the graph assume an initial fixed investment of $100 and that all dividends, if any, were reinvested.
4373
As shown in the chart above, the PEO and other NEOs CAP amounts are directionally aligned with the Company’s TSR. In 2023, the PEO and NEOs CAP amounts included increases in fair value of awards due to the change in the grant date stock price as compared to the fair value at the end of the year as a result of the increase in stock price. We believe the use of equity awards in the Long-Term Incentive Plan strengthens the alignment between our executives’ compensation plans and stockholders’ interests. The TSR peer group is based on the S&P Composite 1500 Health Care Technology Index, which reflects the Company’s industry sector. The Company’s five-year cumulative TSR was above that of the S&P Composite 1500 Health Care Technology Index.
       
Compensation Actually Paid vs. Net Income
CAP versus Net Income

4920
As shown in the chart above, the Company’s net income has increased over the five-year measurement period. The changes in CAP for the PEO and other NEOs are not proportionally correlated with changes in net income over the same measurement period. This is due in part to PEO and other NEO compensation being largely equity-based compensation, as well as the impacts of the impairments and change in valuation allowance on net income in accordance with GAAP. In addition, while net income is one of several factors used to assess Company performance, the Company generally does not use net income as a metric to determine compensation levels or incentive plan payout.
       
Compensation Actually Paid vs. Company Selected Measure
CAP versus Adjusted EBITDA
5617
As shown in the chart above, the PEO and other NEOs’ CAP amounts are directionally aligned with the Company-selected measure of adjusted EBITDA. As discussed in the Long-Term Incentive Plan for 2024 on page 33, adjusted EBITDA is a key performance metric for 2024. However, performance-based equity awarded under the Long-Term Incentive Plan is generally based on a three-year performance period, and the value upon vesting is reflective of the prior three-year performance period. Additionally, while we believe adjusted EBITDA is the most important financial performance measure used by us to link compensation actually paid to our NEOs for the most recently completed fiscal year, this metric was not used by us to link NEO compensation to Company performance in fiscal years ended December 31, 2022, 2021 or 2020.
       
Total Shareholder Return Amount $ 204 182 87 84 96
Peer Group Total Shareholder Return Amount 92 84 115 135 115
Net Income (Loss) $ 14,965,000 $ 15,666,000 $ 21,856,000 $ (22,180,000) $ (44,225,000)
Company Selected Measure Amount | uSD 29,173,000 30,342,000 14,965,000 (4,892,000) 6,346,000
Additional 402(v) Disclosure
Analysis of the Information Presented in the Pay versus Performance Table
In accordance with Item 402(v) of Regulation S-K, we are providing the following graphic descriptions of the relationships between compensation actually paid to our PEO and the average of the compensation actually paid to our remaining NEOs, with (i) our cumulative TSR, (ii) our Peer Group TSR, (iii) our net income, and (iv) our adjusted EBITDA, in each case, for the fiscal years ended December 31, 2020, 2021, 2022, 2023 and 2024.
       
PEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 405,471 $ 1,834,359 $ (254,926) $ (403,374) $ (265,911)
PEO | SPOK Stock Award Value in Compensation Table [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (999,993) (799,999) (999,992) (999,997) (999,998)
PEO | SPOK Fair Value of Equity Awards granted and unvested at FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 864,020 1,260,072 789,016 698,565 758,376
PEO | SPOK Fair Value of Equity Awards granted and vested at FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 172,794 252,014 157,797 139,707 151,680
PEO | SPOK Change In Value Of Prior Year Awards Unvested At FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 37,119 561,848 (68,285) (98,118) (55,304)
PEO | SPOK Change In Value Of Prior Year Awards That vested at FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 331,531 569,261 (71,660) (109,529) (85,651)
PEO | SPOK Fair Value of Awards Forfeited [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 (8,837) (61,802) (34,002) (35,014)
Non-PEO NEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 140,592 625,356 (74,439) (130,881) (66,310)
Non-PEO NEO | SPOK Stock Award Value in Compensation Table [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (385,406) (304,167) (337,497) (369,995) (369,995)
Non-PEO NEO | SPOK Fair Value of Equity Awards granted and unvested at FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 333,005 479,091 266,295 258,469 280,593
Non-PEO NEO | SPOK Fair Value of Equity Awards granted and vested at FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 66,591 95,811 53,254 51,688 56,123
Non-PEO NEO | SPOK Change In Value Of Prior Year Awards Unvested At FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 14,113 189,625 (19,120) (36,304) (11,926)
Non-PEO NEO | SPOK Change In Value Of Prior Year Awards That vested at FYE [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 112,289 167,470 (20,064) (27,404) (15,834)
Non-PEO NEO | SPOK Fair Value of Awards Forfeited [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 0 $ (2,474) $ (17,307) $ (7,335) $ (5,271)